Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

790
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
790

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single cell atlas of lung-resident innate lymphoid cells shows impact of age and dysbiosis on epigenetic and transcriptomic programming.

Mucosal immunology·2026
Same author

Maternal antibiotic exposure-mediated alterations in basal, and allergen-induced lung function are associated with altered recruitment of eosinophils to the developing lung.

Frontiers in immunology·2026
Same author

Targeting CELA1 to Improve Septation in the Mouse Hyperoxia Model of Impaired Alveolar Development.

American journal of respiratory cell and molecular biology·2025
Same author

Microbiota-derived inosine programs protective CD8<sup>+</sup> T cell responses against influenza in newborns.

Cell·2025
Same author

Role of IL10 signaling in the circadian control of host response to Influenza infection.

bioRxiv : the preprint server for biology·2025
Same author

Impact of Viral Lower Respiratory Tract Infection (LRTI) in Early Childhood (0-2 Years) on Lung Growth and Development and Lifelong Trajectories of Pulmonary Health: A National Institutes of Health (NIH) Workshop Summary.

Pediatric pulmonology·2024

Related Experiment Video

Updated: Jan 16, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.5K

Advances in RSV Immunoprophylaxis: Evolution, Efficacy, and Implementation Challenges.

Faris Al Gharaibeh1,2, Ved Deshmukh2, Hitesh Deshmukh1,2

  • 1Division of Neonatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Neoreviews
|September 30, 2025
PubMed
Summary

New respiratory syncytial virus (RSV) prevention strategies, including advanced antibodies and maternal vaccines, show over 70% efficacy in reducing infant hospitalizations. Implementation requires addressing global access and healthcare delivery challenges.

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

17.0K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.3K

Related Experiment Videos

Last Updated: Jan 16, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.5K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

17.0K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.3K

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Respiratory syncytial virus (RSV) causes significant global mortality and morbidity in young children, particularly infants under 12 months.
  • The disease places a substantial burden on global healthcare systems, necessitating effective prevention strategies.
  • Infants under 12 months bear a disproportionate burden of RSV infections and associated mortality.

Purpose of the Study:

  • To review the evolution and current state of RSV prevention strategies.
  • To evaluate the efficacy and implementation challenges of novel RSV interventions.
  • To explore future directions for RSV prevention, considering global access and climate change.

Main Methods:

  • Comprehensive literature review of evidence-based guidelines and clinical trial data.
  • Analysis of economic evaluations for RSV prevention interventions.
  • Exploration of implementation challenges, including healthcare delivery and global equity.

Main Results:

  • Next-generation monoclonal antibodies and novel vaccination approaches in pregnant individuals demonstrate over 70% efficacy in reducing RSV-associated hospitalizations.
  • Economic analyses indicate favorable cost-benefit ratios for current prevention strategies.
  • Implementation necessitates careful consideration of healthcare delivery systems and equitable global access.

Conclusions:

  • Recent advances in RSV prevention offer unprecedented efficacy, significantly reducing disease burden in infants.
  • Successful global implementation hinges on addressing healthcare system capacities and ensuring equitable access to interventions.
  • Future strategies must also consider emerging challenges, such as climate change impacts on RSV seasonality.